Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Other(2)

Detailed Status

unknown2
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting125%
unknown250%
not_yet_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Multidisciplinary Treatment of Chronic Vulvar Pain

NCT03640624
not_yet_recruitingnot_applicable

Poland Integrated Medicines Management (PL-IMM) - Study Assessing the Provision of Complex Clinical Pharmacy Services to Hospitalized Patients

NCT07159932
unknownnot_applicable

Oslo Pharmacist Intervention Study - Effect on Readmissions

NCT02336113
unknown

MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer

NCT03400657

Clinical Trials (4)

Showing 4 of 4 trials
NCT03640624Not Applicable

Multidisciplinary Treatment of Chronic Vulvar Pain

Active Not Recruiting
NCT07159932Not Applicable

Poland Integrated Medicines Management (PL-IMM) - Study Assessing the Provision of Complex Clinical Pharmacy Services to Hospitalized Patients

Not Yet Recruiting
NCT02336113Not Applicable

Oslo Pharmacist Intervention Study - Effect on Readmissions

Unknown
NCT03400657

MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer

Unknown

All 4 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
4